The study will investigate whether the Untire App can help cancer patients and survivors reduce their cancer-related fatigue and improve their quality of life. Participants were recruited in the USA, UK, Canada, Australia, Germany, Spain and The Netherlands.
Participants in the trial were placed into one of the two test groups: the first group received immediate 6-months access to the Untire App, the second group got access after a period of 12 weeks of the study. This allowed researchers to explore fluctuations in patients’ fatigue and to compare that with the fluctuations of fatigue in a group actively using the App. In order to measure participant response, participants were asked to complete ongoing questionnaires throughout the study about their levels of fatigue, quality of life, and other fatigue-related aspects such as physical activity, sleep, mood, and mindfulness.